<?xml version="1.0" encoding="UTF-8"?><rss version="2.0">
    <channel>
    <title>PM Live RSS Feed :: News &amp; Features</title>
 <link>http://www.pmlive.com</link>
        <description>PM Live RSS Feed :: News &amp; Features</description>
        <language>en-gb</language>
        
		<item>
  <title>MHRA chair Breckenridge to advise UK on healthcare ethics</title>
  <link>http://www.pmlive.com/pharma_news/mhra_chair_breckenridge_advise_uk_healthcare_ethics_404818</link>
  <description><![CDATA[
Sir Alasdair Breckenridge appointed first chair of the Emerging Science and Bioethics Advisory Committee
]]></description>
  <pubDate>Wed, 23 May 2012 11:15:08 +0100</pubDate>
  <guid>http://www.pmlive.com/pharma_news/mhra_chair_breckenridge_advise_uk_healthcare_ethics_404818</guid>
</item> <item>
  <title>China has more pharma sales reps than US for first time</title>
  <link>http://www.pmlive.com/pharma_news/china_overtakes_us_number_pharma_sales_reps_404785</link>
  <description><![CDATA[
Reflects increasing industry focus on emerging markets
]]></description>
  <pubDate>Wed, 23 May 2012 11:13:50 +0100</pubDate>
  <guid>http://www.pmlive.com/pharma_news/china_overtakes_us_number_pharma_sales_reps_404785</guid>
</item> <item>
  <title>Industry 'should work closer with payers on drug development'</title>
  <link>http://www.pmlive.com/pharma_news/industry_payers_collaboration_drug_development_404802</link>
  <description><![CDATA[New report says early collaboration could address lack of knowledge regarding risk in biopharmaceutical development]]></description>
  <pubDate>Wed, 23 May 2012 10:44:17 +0100</pubDate>
  <guid>http://www.pmlive.com/pharma_news/industry_payers_collaboration_drug_development_404802</guid>
</item> <item>
  <title>Abbott faces FDA delay for Humira as colitis treatment</title>
  <link>http://www.pmlive.com/pharma_news/abbott_fda_delay_biologic_humira_colitis_drug_404760</link>
  <description><![CDATA[US regulator wants more information on the biologic drug]]></description>
  <pubDate>Wed, 23 May 2012 09:52:37 +0100</pubDate>
  <guid>http://www.pmlive.com/pharma_news/abbott_fda_delay_biologic_humira_colitis_drug_404760</guid>
</item> <item>
  <title>UK’s NICE says Xarelto can be used in atrial fibrillation </title>
  <link>http://www.pmlive.com/pharma_news/uk_nice_xarelto_used_NHS_atrial_fibrillation_404703</link>
  <description><![CDATA[ Will compete with Boehringer’s Pradaxa in prevention of stroke ]]></description>
  <pubDate>Wed, 23 May 2012 07:00:12 +0100</pubDate>
  <guid>http://www.pmlive.com/pharma_news/uk_nice_xarelto_used_NHS_atrial_fibrillation_404703</guid>
</item> <item>
  <title>GE Healthcare signs cell therapy research partnership</title>
  <link>http://www.pmlive.com/pharma_news/ge_healthcare_cell_therapy_research_partnership_karolinska_404704</link>
  <description><![CDATA[Will work with Karolinska University Hospital to investigate clinical technology and workflow needs]]></description>
  <pubDate>Wed, 23 May 2012 06:30:06 +0100</pubDate>
  <guid>http://www.pmlive.com/pharma_news/ge_healthcare_cell_therapy_research_partnership_karolinska_404704</guid>
</item> <item>
  <title>The early bird: planning ahead in communications</title>
  <link>http://www.pmlive.com/pharma_news/the_early_bird_planning_ahead_communications_403850</link>
  <description><![CDATA[EPSCP has emerged as a major impetus in pharmaceutical communications development. What are the important considerations and benefits from doing it successfully? ]]></description>
  <pubDate>Wed, 23 May 2012 05:30:21 +0100</pubDate>
  <guid>http://www.pmlive.com/pharma_news/the_early_bird_planning_ahead_communications_403850</guid>
</item> <item>
  <title>PRA expands its European operations with new UK and Dutch offices</title>
  <link>http://www.pmlive.com/pharma_news/pra_expands_european_cro_operations_404468</link>
  <description><![CDATA[Will open new base in Utrecht and relocate its existing Reading, UK offices to a larger site]]></description>
  <pubDate>Tue, 22 May 2012 11:11:34 +0100</pubDate>
  <guid>http://www.pmlive.com/pharma_news/pra_expands_european_cro_operations_404468</guid>
</item> <item>
  <title>Daiichi to research cancer drugs with Japan’s National Cancer Centre</title>
  <link>http://www.pmlive.com/pharma_news/daiichi_research_cancer_drugs_japan_national_cancer_centre_404464</link>
  <description><![CDATA[
Deal also covers promotion of public health
]]></description>
  <pubDate>Tue, 22 May 2012 11:11:02 +0100</pubDate>
  <guid>http://www.pmlive.com/pharma_news/daiichi_research_cancer_drugs_japan_national_cancer_centre_404464</guid>
</item> <item>
  <title>Boehringer Ingelheim's Dr Susan Anton joins Icon</title>
  <link>http://www.pmlive.com/pharma_news/icon_cro_boehringer_ingelheim_dr_susan_anton_404453</link>
  <description><![CDATA[The CRO also appoints Dr Pui Leung, boosting its early phase and epidemiology and risk management teams]]></description>
  <pubDate>Tue, 22 May 2012 11:01:31 +0100</pubDate>
  <guid>http://www.pmlive.com/pharma_news/icon_cro_boehringer_ingelheim_dr_susan_anton_404453</guid>
</item> <item>
  <title>Xarelto backed for ACS ahead of FDA advisory panel</title>
  <link>http://www.pmlive.com/pharma_news/xarelto_backed_acs_ahead_fda_advisory_panel_404404</link>
  <description><![CDATA[Documents released showing agency supports Johnson &amp; Johnson/Bayer's drug in extra indication]]></description>
  <pubDate>Tue, 22 May 2012 10:04:52 +0100</pubDate>
  <guid>http://www.pmlive.com/pharma_news/xarelto_backed_acs_ahead_fda_advisory_panel_404404</guid>
</item> <item>
  <title>Bayer’s Nexavar fails in another lung cancer study</title>
  <link>http://www.pmlive.com/pharma_news/bayers_nexavar_fails_in_another_lung_cancer_study_404401</link>
  <description><![CDATA[Dents prospects for approval in extra indication]]></description>
  <pubDate>Tue, 22 May 2012 09:57:55 +0100</pubDate>
  <guid>http://www.pmlive.com/pharma_news/bayers_nexavar_fails_in_another_lung_cancer_study_404401</guid>
</item> <item>
  <title>GSK agrees to co-promote Auxilium’s Testim in US</title>
  <link>http://www.pmlive.com/pharma_news/gsk_agrees_to_co-promote_auxiliums_testim_in_us_404194</link>
  <description><![CDATA[US biopharma Auxilium raises financial guidance for year based on deal for its testosterone gel brand]]></description>
  <pubDate>Tue, 22 May 2012 07:00:06 +0100</pubDate>
  <guid>http://www.pmlive.com/pharma_news/gsk_agrees_to_co-promote_auxiliums_testim_in_us_404194</guid>
</item> <item>
  <title>Country report: The healthcare market in South Korea</title>
  <link>http://www.pmlive.com/find_an_article/allarticles/categories/General/2012/may/features/country_report_healthcare_market_south_korea_400599</link>
  <description><![CDATA[The South Korean pharmaceutical market has had consistent double-digit growth for five years and is considered the fastest-growing developed country by IMS Health]]></description>
  <pubDate>Tue, 22 May 2012 06:30:07 +0100</pubDate>
  <guid>http://www.pmlive.com/find_an_article/allarticles/categories/General/2012/may/features/country_report_healthcare_market_south_korea_400599</guid>
</item> <item>
  <title>UCB signs epilepsy research pact with Imperial College London</title>
  <link>http://www.pmlive.com/pharma_news/ucb_research_epilepsy_imperial_college_london_404095</link>
  <description><![CDATA[ Belgian pharma firm also launches epilepsy centre in Glasgow during National Epilepsy Awareness Week ]]></description>
  <pubDate>Mon, 21 May 2012 11:06:08 +0100</pubDate>
  <guid>http://www.pmlive.com/pharma_news/ucb_research_epilepsy_imperial_college_london_404095</guid>
</item>     </channel>
</rss>
